Neonatal lethal osteochondrodysplasia with low serum levels of alkaline phosphatase and osteocalcin

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 1233-1240

  Wyckoff, Myra H ^a   El Turk, Chirine ^a   Laptook, Abbot ^a   Timmons, Charles ^a   Gannon, Francis H ^b   Zhang, Xiafang ^c   Mumm, Steven ^c,d   Whyte, Michael P ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; AUTOPSY; BONE MALFORMATION; BONE MINERALIZATION; CASE REPORT; CHONDRODYSPLASIA; CLAVICLE; CLEIDOCRANIAL DYSPLASIA; CONFERENCE PAPER; FATALITY; GROWTH PLATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; LIMB MALFORMATION; MALE; MANDIBLE; NEWBORN; NEWBORN DISEASE; NUCLEOTIDE SEQUENCE; OSTEOPENIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKULL MALFORMATION; THORAX MALFORMATION; VERTEBRA MALFORMATION;

ALKALINE PHOSPHATASE; CHILD, PRESCHOOL; FATAL OUTCOME; HUMANS; HYPOCALCEMIA; MALE; OSTEOCALCIN; OSTEOCHONDRODYSPLASIAS; SPINE;

EID: 14044268243     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0251     Document Type: Conference Paper

References (55)

1. Horton WA, Hecht JT 2002 Chondrodysplasias: general concepts and diagnostic and management considerations. In: Royce PM, Steinmann B, eds. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects. 2nd ed, New York: Wiley-Liss; 901-909
2. Spranger JW, Brill PW, Poznanski AK 2002 Bone dysplasias: an atlas of genetic disorders of skeletal development. 2nd ed. New York: Oxford University Press
3. Stoll C, Dott B, Roth MP, Alembik Y 1989 Birth prevalence rates of skeletal dysplasias. Clin Genet 35:88-92
4. McKusick VA 1998 Mendelian inheritance in man: a catalog of human genes and genetic disorders. 12th ed. Baltimore: Johns Hopkins University Press
5. McKusick VA 2000 Online Mendelian inheritance in man, OMIM. Baltimore, MD: McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University, and Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine
6. Houston CS, Awen CF, Kent HP 1972 Fatal neonatal dwarfism. J Can Assoc Radiol 23:45-61
7. Smith LN, Dayal VH, Monga M 1999 Prior knowledge of obstetric gestational age and possible bias of Ballard score. Obstet Gynecol 93:712-714
8. Whyte MP, Eddy MC, Podgornik MN, McAlister WH 1999 Polycystic bone disease: a new, autosomal dominant disorder. J Bone Miner Res 14:1261-1271
9. Whyte MP 2001 Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New-York: McGraw-Hill; 5313-5329
10. Whyte MP, Mahuren JD, Vrabel LA, Coburn SP 1985 Markedly increased circulating pyridoxal-5′-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752-756
11. Mumm S, Jones J, Finnegan P, Henthorn P, Podgornik MN, Whyte MP 2002 Denaturing gradient gel electrophoresis analysis of the tissue non-specific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab 75:143-153
12. Quack I, Vonderstrass B, Stock M, Aylsworth AS, Becker A, Brueton L, Lee PJ, Majewski F, Mulliken JB, Suri M, Zenker M, Mundlos S, Otto F 1999 Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet 65:1268-1278
13. Zhang YW, Yasui N, Kakazu N, Abe T, Takada K, Imai S, Sato M, Nomura S, Ochi T, Okuzumi S, Nogami H, Nagai T, Ohashi H, Ito Y 2000 PEBP2αA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene 244:21-28
14. Xiao ZS, Thomas R, Hinson TK, Quarles LD 1998 Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197
15. Tou L, Quibria N, Alexander JM 2003 Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Mol Cell Endocrinol 205:121-129
16. Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, Chodirker BN 1993 A homoallelic Gly317->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics 17:215-217
17. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP 1992 Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci USA 89:9924-9928
18. Whyte MP 2002 Hypophosphatasia: nature's window on alkaline phosphatase function in man. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 2nd ed. San Diego: Academic Press; 1229-1248
19. Whyte MP 1994 Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439-461
20. Spentchian M, Merrien Y, Herasse M, Dobbie Z, Glaser D, Holder SE, Ivarsson SA, Kostiner D, Mansour S, Norman A, Roth J, Stipoljev F, Taillemite JL, van der Smagt JJ, Serre JL, Simon-Bouy B, Taillandier A, Mornet E 2003 Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat 22:105-106
21. Whyte MP 2000 Hypophosphatasia. In: Econs MJ, ed. The genetics of osteoporosis and metabolic bone disease. Totowa, NJ: Humana Press; 335-356
22. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL 2002 Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445-9449
23. Caswell AM, Whyte MP, Russell RG 1991 Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects. Crit Rev Clin Lab Sci 28:175-232
24. Shohat M, Rimoin DL, Gruber HE, Lachman RS 1991 Perinatal lethal hypophosphatasia: clinical, radiologic and morphologic findings. Pediatr Radiol 21:421-427
25. Jones KL 1997 Smith's recognizable patterns of human malformation. 5th ed. Philadelphia: W. B. Saunders
26. Whyte MP 1988 "Spur-limbed" dwarfism identified as hypophosphatasia. Dysmorphol Clin Genet 2:126-127
27. Pauli RM, Modaff P, Sipes SL, Whyte MP 1999 Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken. Am J Med Genet 86:434-438
28. Mundlos S 1999 Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 36:177-182
29. Levin EJ, Sonnennschein H 1963 Cleidocranial dysostosis. NY J Med 63:1562-1566
30. Moore CA, Ayangade G, Okolo P, Bull MJ, Whyte MP, Bixler D 1992 Cleidocranial dysplasia: a natural history study including evaluation of a five generation family. Proc Greenwood Genetic Center 11:91 (Abstract)
31. Bull MJ, Weaver DD, Bender H, White R 1992 Respiratory failure in cleidocranial dysplasia - a rare finding in a known disorder. Proc Greenwood Genetic Center 11:107-108 (Abstract)
32. Unger S, Mornet E, Mundlos S, Blaser S, Cole DE 2002 Severe cleidocranial dysplasia can mimic hypophosphatasia. Eur J Pediatr 161:623-626
33. Morava E, Karteszi J, Weisenbach J, Caliebe A, Mundlos S, Mehes K 2002 Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia. Eur J Pediatr 161:619-622
34. Royce PM, Blumberg A, Zurbrugg RP, Zimmermann A, Colombo JP, Steinmann B 1988 Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia. Eur J Pediatr 147:626-631
35. Oyer CE, Tatevosyants NG, Cortez SC, Hornstein A, Wallach M 1998 Cleidocranial dysplasia with neonatal death due to central nervous system injury in utero: case report and literature review. Pediatr Dev Pathol 1:314-318
36. Chitayat D, Hodgkinson, Azouz EM 1992 Intrafamilial variability in cleidocranial dysplasia: a three generation family. Am J Med Genet 42:298-303
37. Mundlos S, Mulliken JB, Abramson DL, Warman ML, Knoll JH, Olsen BR 1995 Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet 4:71-75
38. Feldman GJ, Robin NH, Brueton LA, Robertson E, Thompson EM, Siegel-Bartelt J, Gasser DL, Bailey LC, Zackai EH, Muenke M 1995 A gene for cleidocranial dysplasia maps to the short arm of chromosome 6. Am J Hum Genet 56:938-943
39. Gelb BD, Cooper E, Shevell M, Desnick RJ 1995 Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletion. Am J Med Genet 58:200-205
40. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR 1997 Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779
41. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G 1997 Missense mutations abolishing DNA binding of the osteoblasr-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16:307-310
42. Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D, Gelb BD, Pirinen S, Berry SA, Greenberg CR, Karsenty G, Lee B 1999 CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet 8:2311-2316
43. Zackai EH, Robin NH, McDonald-McGinn DM 1997 Sibs with cleidocranial dysplasia born to normal parents: germ line mosaicism? Am J Med Genet 69:348-351
44. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronston RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
45. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771
46. Gundberg C 1998 Biology, physiology, and clinical chemistry of osteocalcin. J Clin Ligand Assay 21:128-138
47. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452
48. Fedde KN, Whyte MP 1990 Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5′-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet 47:767-775
49. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29
50. Ducy P 2000 Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219:461-471
51. Crane JP, Heise RL 1981 New syndrome in three affected siblings. Pediatrics 68:235-237
52. Shibata H, Fukushi M, Igarashi A, Misumi Y, Ikehara Y, Ohashi Y, Oda K 1998 Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala162→Thr mutation associated with lethal hypophosphatasia. J Biochem (Tokyo) 123:968-977
53. Macfarlane JD, Frolich M, Papapoulos SE 1991 Serum osteocalcin levels before and after 1,25 dihydroxy-vitamin D stimulation in a family with hypophosphatasia. Bone 12:261-263
54. Deeb AA, Bruce SN, Morris AA, Cheetham TD 2000 Infantile hypophosphatasia: disappointing results of treatment. Acta Paediatr 89:730-733
55. Nangaku M, Sato N, Sugano K, Takaku F 1991 Hypophosphatasia in an adult: a case report. Jpn J Med 30:47-52